Safe Antitussives in Chronic Kidney Disease

First-Line Antitussive Recommendations for CKD

Dextromethorphan is the antitussive of choice for nonproductive dry cough in CKD patients due to substantial benefit and favorable safety profile compared to other antitussives 2
Maximum cough suppression occurs at 60 mg doses with prolonged effect, and no renal dose adjustment is required 2
Dextromethorphan is more effective than codeine in controlling cough with fewer side effects 2
Honey and lemon mixtures provide effective symptomatic relief without renal concerns 1, 2
Menthol lozenges or inhalation offer short-term suppression through cold and menthol receptors 1, 2
Adequate hydration should be encouraged for symptom management 2

Ipratropium bromide is the only inhaled anticholinergic recommended for cough suppression in chronic bronchitis, regardless of renal function 3, 1, 4
Peripheral cough suppressants (levodropropizine, moguisteine) are recommended if available, though not marketed in the United States 3, 1
Hypertonic saline and erdosteine increase cough clearance short-term without renal concerns 1
Both peripheral and central cough suppressants have limited efficacy for URI-related cough 3, 1
Focus on simple home remedies (honey, lemon, hydration, menthol) rather than pharmacologic agents for URI-related cough 1
Albuterol should not be used for cough not due to asthma in CKD patients 3, 1

Do not use antibiotics for nonproductive cough due to viral infections, even when phlegm is present 2